Abstract: Methods of screening human female subject for a risk of ovarian cancer are described. High levels of calcium in serum are shown to be significantly positively associated with the risk of ovarian cancer and can advantageously be used to triage women into risk categories for more intensive testing. Also included are preoperative methods of determining if an adnexal mass is likely to be malignant or benign.
Type:
Grant
Filed:
January 6, 2014
Date of Patent:
March 29, 2016
Assignees:
WISCONSIN ALUMNI RESEARCH FOUDATION, WAKE FOREST UNIVERSITY HEALTH SCIENCES
Inventors:
Halcyon Gerald Skinner, Gary G. Schwartz
Abstract: This invention discloses 1&agr;-hydroxy-2-methylene-19-nor-pregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat immune disorders in humans as well as renal osteodystrophy.
Type:
Grant
Filed:
February 18, 2002
Date of Patent:
May 20, 2003
Assignee:
Wisconsin Alumni Research Foudation
Inventors:
Hector F. DeLuca, Lori A. Plum, Margaret Clagett-Dame